Le Lézard
Classified in: Health
Subjects: PSF, CFG

Public Advisory - Fake Viagra seized from Jug City store in Scarborough, ON


OTTAWA, ON, April 26, 2024 /CNW/ -

Summary

Viagra (Back) (CNW Group/Health Canada (HC))

Viagra (Front) (CNW Group/Health Canada (HC))

Affected Products
Counterfeit Viagra, 100 mg sildenafil tablets

Issue
Health Canada has seized counterfeit Viagra from a Jug City store in Scarborough, Ontario (96 Dearham Wood). This is in addition to several other unauthorised sexual enhancement products seized from the same store.  

The counterfeit Viagra was sold in individual blister packs with no other packaging. Authorized Viagra is usually sold with an outer carton and a leaflet outlining the directions for use. Other indicators that the product is fake include an expiry date in an incorrect format ("EXP032 025") and no lot number printed on the blister pack.

Counterfeit drugs are made to look like authentic products, but they are not the same and they may not contain the drug at all. They can pose serious health risks if they contain a higher dosage than shown on the label, and could contain contaminants and hidden ingredients. Unlike authorized and authentic drug products, counterfeit drugs have not been assessed by Health Canada for safety, effectiveness, and quality. Selling counterfeit health products is illegal.

Health Canada has confirmed with the authorized manufacturer of Viagra that the seized product is counterfeit. Like authentic Viagra, the seized product is labelled to contain the prescription drug sildenafil. Sildenafil should be used only under the supervision of a health care professional. It should not be used by individuals taking any kind of nitrate drug (e.g., nitroglycerin) as it can cause potentially life-threatening low blood pressure. Individuals with heart problems are at increased risk of cardiovascular side effects such as heart attack, stroke, chest pain, high blood pressure, and abnormal heartbeat. Other possible side effects include headache, facial flushing, indigestion, dizziness, abnormal vision, and hearing loss.

Health Canada reminds consumers that the best way to make sure their prescription drugs are authentic is to buy them from a licensed pharmacy. Moreover, prescription drugs should be taken only under the advice and supervision of a health care professional because they are used to treat specific health conditions and may cause serious side effects. Prescription drugs can only be legally sold to consumers in Canada with a prescription and cannot be sold in convenience stores.

For more information regarding Health Canada's approach to counterfeit health products, please consult Health Canada's Policy on Counterfeit Health Products.

What you should do

Également disponible en français

SOURCE Health Canada (HC)


These press releases may also interest you

at 16:40
Johnson & Johnson will participate in the Goldman Sachs 45th Annual Global Healthcare Conference on Wednesday, June 12th, at the Loews Miami Beach Hotel, Miami Beach, Florida. Jennifer Taubert, Executive Vice President, Worldwide Chairman,...

at 16:37
Inhibrx, Inc. ("Inhibrx," or the "Company") today announced that it has set a record date of May 17, 2024 (the "Record Date") for the previously announced distribution by the Company of 92% of shares of common stock of its subsidiary, Inhibrx...

at 16:35
DiaMedica Therapeutics Inc. , a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and cardio-renal disease, today provided a business update and financial results for the quarter ended March...

at 16:35
Castle Biosciences, Inc. , a company improving health through innovative tests that guide patient care, today announced new data from a study further confirming the performance of its DecisionDx-UM test as a robust independent predictor of...

at 16:30
Catalent, Inc. ("Catalent"), the leader in enabling the development and supply of better treatments for patients worldwide, today announced financial results for the third quarter of fiscal 2024, which ended March 31, 2024. "I am pleased to report...

at 16:30
MediPharm Labs Corp. ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce it will release its first quarter financial results  for the period ended March 31,...



News published on and distributed by: